IP Library Granted Patent US 9,409,868
Granted Patent B2
US 9,409,868 · App. 14/374,445 · Granted Aug 9, 2016

Inhibitors of rho associated protein kinases (ROCK) and methods of use

Inventors: Ernst Schonbrunn (Tampa, FL); Rongshi Li (Omaha, NE); Said M. Sebti (Tampa, FL)
Assignee: H. Lee Moffin Cancer Center and Research Institute, Inc.
C07D231/56A61K31/416A61K31/4418A61K45/06A61N5/10C07D213/36C07D213/40
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,409,868
App. No.
14/374,445
Granted
Aug 9, 2016
Kind
B2
Abstract

Compounds and compositions having activity as inhibitors of Rho-associated proteinkinases (ROCKs), and methods of making and using the subject compounds are disclosed.

Claims (13)

1. A compound having the chemical structure shown in Formula IV

wherein

R is H, alkyl, acetyl, or heteroalkyl;

R 1 is H, alkyl, acetyl, or heteroalkyl;

R 8 and R 9 are, independently of one another, H, —OH, acetyl, —C(O)NH 2 , alkyl, cycloalkyl, hereterocycloalkyl, aryl, or heteroaryl, wherein any one of the alkyl, cycloalkyl, hereterocycloalkyl, aryl, or heteroaryl groups is optionally substituted with one or more of —OH, —NO 2 , —NH 2 , —NR 6 R 7 , carbonyl, alkoxy, alkyl, —OCX 3 , —OCHX 2 , —OCH 2 X, or halogen, or both R 8 together form a carbonyl; and

R 10 is cycloalkyl, aryl, or heteroaryl, any of which is optionally substituted with one or more of —OH, —C(O)NH 2 , —C(O)CH 3 , —NO 2 , —NH 2 , —NR 6 R 7 , carbonyl, alkyl, alkoxy, alkylalkoxy, alkoxylalkoxy, halogenated alkoxyl, cycloalkyl, heterocycloalkyl, heteroarylcarbonyl, aryl, heteroaryl, —OCX 3 , —OCHX 2 , —OCH 2 X, —OSO 2 CH 3 , or -tosyl;

R 6 and R 7 are, independently, H, alkyl, —SO 2 CH 3 , —C(O)CH 3 , or —C(O)NH 2 ;

X is independently H or halogen; and

n is 2 or 3.

2. The compound of claim 1 , wherein n is 2.

3. The compound of claim 1 , wherein R 8 and R 9 are, independently, H, alkyl, or alkyl substituted with —OH, —NH 2 , alkoxy, or halogen.

4. The compound of claim 1 , wherein R 10 is an aryl or heteroaryl, any of which is optionally substituted in the ortho-, meta-, orpara-position with —OH, —CO 2 CH 3 , —C(O)NH 2 , —NO 2 , —NH 2 , —NR 6 R 7 , alkoxy, alkylalkoxy, alkyl, —OSO 2 CH 3 , or tosyl.

5. The compound of claim 1 having the formula

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2016
From: SCHONBRUNN, ERNST; LI, RONGSHI; SEBTI, SAID M.
To: H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC.
Reel/Frame 038394/0885 →
Continuity (3)
Provisional Application 61590283 · Jan 24, 2012
Provisional Application 61590573 · Jan 25, 2012
Related Publication 20140336440A1 · Nov 13, 2014